STOCK TITAN

OmniAb Stock Price, News & Analysis

OABIW NASDAQ

Company Description

OmniAb (NASDAQ: OABIW) is a publicly traded company in the Services-commercial Physical & Biological Research sector.

OABIW stock has declined 54.7% over the past year. Shares last traded at $0.1070.

On a trailing twelve-month basis, OmniAb reported revenue of $18.7M with net income of -$64.8M and diluted earnings per share of $-0.57. The company operates at a net profit margin of -347.0%.

This page provides a comprehensive overview of OABIW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-54.7%
Performance 1 year

OmniAb (OABIW) stock last traded at $0.1070. Over the past 12 months, the stock has lost 54.7%.

OABIW Rankings

Latest News

No recent news available for OABIW.

SEC Filings

OmniAb has filed 10 recent SEC filings, including 4 Form 4, 2 Form 10-Q, 2 Form 8-K, 2 Form DEF 14A. The most recent filing was submitted on May 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OABIW SEC filings →

Financial Highlights

OmniAb generated $18.7M in revenue over the trailing twelve months, operating income reached -$69.0M (-369.5% operating margin), and net income was -$64.8M, reflecting a -347.0% net profit margin. Diluted earnings per share stood at $-0.57. The company generated -$36.5M in operating cash flow. With a current ratio of 4.02, the balance sheet reflects a strong liquidity position.

$18.7M
Revenue (TTM)
-$64.8M
Net Income (TTM)
-$36.5M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in OmniAb (OABIW) currently stands at 9.6 thousand shares, down 33.6% from the previous reporting period, representing 0.0% of the shares outstanding. Over the past 12 months, short interest has decreased by 33.9%.

Days to Cover History

Last 12 Months

Days to cover for OmniAb (OABIW) currently stands at 1.1 days, down 27.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 319.6 days.

OABIW Company Profile & Sector Positioning

OmniAb (OABIW) operates in the Services-commercial Physical & Biological Research sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of OmniAb (OABIW)?

The current stock price of OmniAb (OABIW) is $0.107 as of June 16, 2026.

What is the revenue (TTM) of OmniAb (OABIW) stock?

The trailing twelve months (TTM) revenue of OmniAb (OABIW) is $18.7M.

What is the net income of OmniAb (OABIW)?

The trailing twelve months (TTM) net income of OmniAb (OABIW) is -$64.8M.

What is the earnings per share (EPS) of OmniAb (OABIW)?

The diluted earnings per share (EPS) of OmniAb (OABIW) is $-0.57 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of OmniAb (OABIW)?

The operating cash flow of OmniAb (OABIW) is -$36.5M. Learn about cash flow.

What is the profit margin of OmniAb (OABIW)?

The net profit margin of OmniAb (OABIW) is -347.0%. Learn about profit margins.

What is the operating margin of OmniAb (OABIW)?

The operating profit margin of OmniAb (OABIW) is -369.5%. Learn about operating margins.

What is the current ratio of OmniAb (OABIW)?

The current ratio of OmniAb (OABIW) is 4.02, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of OmniAb (OABIW)?

The operating income of OmniAb (OABIW) is -$69.0M. Learn about operating income.